Free Trial
→ Buffett's Final Warning: 'The Dollar Is Going to Hell' (From Decentralized Masters) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
$2.70
-1.5%		$5.12
$2.70
▼
$179.19
$1.50M-0.071.39 million shs12,302 shs
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.25
-3.2%		$0.28
$0.24
▼
$0.45
$26.27M0.47690,425 shs405,402 shs
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
$0.19
$0.19
$20.00
▼
$22.69
$1.41M0.9569,150 shs3,000 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
-1.46%-17.18%-28.00%-73.91%-97.62%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-3.19%-12.11%-9.56%-5.38%-40.87%
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
0.00%0.00%0.00%0.00%-99.08%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
$2.70
-1.5%		$5.12
$2.70
▼
$179.19
$1.50M-0.071.39 million shs12,302 shs
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.25
-3.2%		$0.28
$0.24
▼
$0.45
$26.27M0.47690,425 shs405,402 shs
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
$0.19
$0.19
$20.00
▼
$22.69
$1.41M0.9569,150 shs3,000 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
-1.46%-17.18%-28.00%-73.91%-97.62%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-3.19%-12.11%-9.56%-5.38%-40.87%
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
0.00%0.00%0.00%0.00%-99.08%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
1.50
ReduceN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
2.50
Moderate Buy$5.502,135.77% Upside
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
2.58
Moderate Buy$0.19N/A

Current Analyst Ratings Breakdown

Latest RSE, ROOF, IGC, and ARTL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
8/28/2026
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold
(Data available from 10/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
N/AN/AN/AN/A($17.03) per shareN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$1.27M20.02N/AN/A$0.08 per share3.08
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
-$12.88M-$151.22N/AN/AN/AN/A-518.27%-194.29%11/17/2026 (Estimated)
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/A-$0.07N/AN/AN/AN/A-99.21%-74.18%N/A
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
N/AN/A26.87N/AN/AN/AN/AN/AN/A

Latest RSE, ROOF, IGC, and ARTL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/A-$0.03N/A-$0.03N/A$0.27 million
8/12/2026Q2 2026
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
-$6.48-$0.89+$5.59-$8.01N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
N/AN/AN/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/AN/A
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
$0.57300.00%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
N/A
3.00
3.00
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.02
0.39
0.19
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
0.87%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.87%
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
N/A

Insider Ownership

CompanyInsider Ownership
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
3.20%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
23.66%
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
7550,000530,000Not Optionable
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
70103.38 million78.92 millionN/A
NYLI CBRE NextGen Real Estate ETF stock logo
ROOF
NYLI CBRE NextGen Real Estate ETF
N/A7.40 millionN/ANot Optionable

Recent News About These Companies

NYLI CBRE Real Estate Fund;C
June 24, 2026  |  wsj.comhttps://www.wsj.com/market-data/quotes/mutualfund/CRCRX
NYLI CBRE Real Estate Fund;I
June 18, 2026  |  barrons.comhttps://www.barrons.com/market-data/funds/crarx
NYLI CBRE Real Estate Fund
October 21, 2025  |  money.usnews.comhttps://money.usnews.com/funds/mutual-funds/real-estate/nyli-cbre-real-estate-fund/clarx
NYLI CBRE Real Estate Fund
October 21, 2025  |  money.usnews.comhttps://money.usnews.com/funds/mutual-funds/real-estate/nyli-cbre-real-estate-fund/clarx
When (ROOF) Moves Investors should Listen
October 6, 2024  |  news.stocktradersdaily.comN
ROOF NYLI CBRE NextGen Real Estate ETF
September 21, 2024  |  seekingalpha.comhttps://seekingalpha.com/symbol/ROOF/risk
When the Price of (ROOF) Talks, People Listen
August 7, 2024  |  news.stocktradersdaily.comN
VY® CBRE Real Estate A
August 3, 2024  |  morningstar.comM
MainStay CBRE Real Estate I
July 31, 2024  |  morningstar.comM
Trend Tracker for (ROOF)
July 28, 2024  |  news.stocktradersdaily.comN
MainStay CBRE Real Estate A
July 25, 2024  |  morningstar.comM
MainStay CBRE Real Estate R6
July 24, 2024  |  morningstar.comM
VY® CBRE Global Real Estate I
July 19, 2024  |  morningstar.comM
MainStay CBRE Real Estate Fund;I
May 25, 2024  |  wsj.comhttps://www.wsj.com/market-data/quotes/mutualfund/CRARX/
IndexIQ’S IQ U.S. Real Estate Small Cap ETF Completes Transition to Track IQ CBRE NextGen Real Estate Index (Ticker: ROOF)
September 1, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/indexiq-iq-u-real-estate-130000520.html?.tsrc=rss
IQ U.S. Real Estate Small Cap ETF (ROOF)
August 30, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/quote/ROOF/history
Buffer ETFs are beating the market in 2022 and delivering protection for patient investors
August 14, 2022  |  cnbc.comhttps://www.cnbc.com/2022/08/14/buffer-etfs-are-beating-the-market-in-2022-and-delivering-protection-for-patient-investors.html
Carter's's Return On Invested Capital Insights
August 1, 2022  |  msn.comhttps://www.msn.com/en-us/finance/savingandinvesting/carterss-return-on-invested-capital-insights/ar-AA10btMQ
US small caps attract bargain-hunting investors with cheap valuations
July 31, 2022  |  msn.comhttps://www.msn.com/en-ae/money/news/us-small-caps-attract-bargain-hunting-investors-with-cheap-valuations/ar-AA108UBE
Northstar Announces 2022 AGSM Results
July 29, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/northstar-announces-2022-agsm-results-120000891.html?.tsrc=rss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Digital illustration of a central computer chip connected by glowing blue and green lines to server nodes over a world map.
These 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity Push
By Thomas Hughes | September 20, 2026
Digital illustration of a data center control room with monitors, cloud icons, and small robots linked by network graphics.
These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
By Chris Markoch | September 19, 2026
Digital illustration of a red network of nodes and data being blocked by blue shield icons, symbolizing cybersecurity defense.
2 Cybersecurity Stocks Breaking Out as AI Continues to Be a Tailwind
By Ryan Hasson | September 27, 2026
Exterior of an AutoZone retail store with illuminated logo, glass entrance, and parking lot at sunset.
AutoZone Shifts Gears, On Track to Reverse Course and Price Recovery
By Thomas Hughes | September 23, 2026
Illustration of a glowing red shield surrounded by blue data streams in a server data center, symbolizing cybersecurity.
Bernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?
By Chris Markoch | September 29, 2026
Artelo Biosciences stock logo

Artelo Biosciences NASDAQ:ARTL

$2.70 -0.04 (-1.46%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$2.74 +0.04 (+1.48%)
As of 10/16/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

IGC Pharma stock logo

IGC Pharma NYSEAMERICAN:IGC

$0.25 -0.01 (-3.19%)
Closing price 10/16/2026 04:10 PM Eastern
Extended Trading
$0.25 +0.00 (+0.41%)
As of 10/16/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

NYLI CBRE NextGen Real Estate ETF stock logo

NYLI CBRE NextGen Real Estate ETF NYSEARCA:ROOF

$0.19 0.00 (0.00%)
As of 06/10/2026

The IQ U.S. Real Estate Small Cap ETF (ROOF) is an exchange-traded fund that is based on the IQ CBRE NextGen Real Estate index. The fund tracks a tier-weighted index of developed market companies classified under real estate sectors that are expected to benefit from trends affecting property sectors in the global economy. ROOF was launched on Jun 14, 2011 and is managed by IndexIQ.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas